An antibiotic stewardship program is a coordinated effort within a healthcare facility to ensure that antibiotics are prescribed only when needed, at the right dose, for the right duration. The goal is straightforward: better patient outcomes and fewer drug-resistant infections. These programs operate in hospitals, nursing homes, and outpatient clinics, and they’ve become a regulatory expectation rather than an optional initiative. Hospitals with active stewardship programs consistently save between $200,000 and $400,000 per year in reduced antibiotic spending alone.
Why Stewardship Programs Exist
Every time an antibiotic is used, bacteria get a chance to adapt. Unnecessary or poorly targeted prescriptions accelerate that process, breeding resistant organisms that are harder and more expensive to treat. One of the most dangerous consequences is C. difficile infection, a severe and sometimes fatal gut infection directly linked to broad-spectrum antibiotic overuse. Stewardship programs exist to slow this cycle by making antibiotic prescribing more precise.
Beyond resistance, antibiotics carry real risks for individual patients: allergic reactions, organ toxicity, and disruption of healthy gut bacteria. A stewardship program treats antibiotics like any other high-risk intervention, applying checks and oversight to make sure the benefit outweighs the harm.
The CDC’s Seven Core Elements
The CDC developed a framework of seven core elements that define what a successful hospital stewardship program looks like. These aren’t vague suggestions. They form the structural blueprint that accreditation bodies and federal agencies expect hospitals to follow.
- Leadership commitment: Hospital leadership dedicates budget, staff, and technology resources to the program. Stewardship needs to be an institutional priority, not a side project.
- Accountability: A physician and pharmacist (or both as co-leaders) are formally appointed to manage the program and its outcomes.
- Pharmacy expertise: A pharmacist with training in infectious disease or antibiotic use plays a central role in reviewing and guiding prescribing decisions.
- Action: The program implements specific interventions to change prescribing behavior, such as requiring approval before certain antibiotics can be ordered, or reviewing prescriptions after they’re written and giving feedback to the prescriber.
- Tracking: The program monitors how antibiotics are being used across the facility, along with outcomes like C. difficile infection rates and resistance patterns.
- Reporting: Data on antibiotic use and resistance trends are shared regularly with prescribers, pharmacists, nurses, and hospital leadership.
- Education: Staff and patients receive training on the risks of antibiotic overuse, the threat of resistance, and what optimal prescribing looks like.
How Stewardship Changes Prescribing
The two primary tools stewardship programs use are preauthorization and prospective audit with feedback. They work differently, and the choice between them shapes how aggressively a program controls antibiotic use.
Preauthorization means a prescriber must get approval before ordering certain antibiotics, typically the broadest-spectrum or most expensive ones. This creates a gatekeeping function. A CDC-funded study found that during a period when preauthorization was the primary strategy, both total antibiotic use and broad-spectrum antibiotic use declined steadily month over month.
Prospective audit with feedback takes a lighter touch. Prescribers can order what they want, but a stewardship pharmacist or physician reviews the order afterward and recommends changes. It’s less restrictive and generally better received by medical staff, but the same study found that when a hospital switched from preauthorization to audit-and-feedback for several key antibiotics, total antibiotic use and broad-spectrum use both increased significantly. Hospital length of stay also went up. The takeaway: the review-and-suggest approach gives prescribers more autonomy, but it may not control overuse as effectively.
A third common strategy is de-escalation, which means starting a patient on a broad-spectrum antibiotic when the infection source is unknown, then narrowing to a more targeted drug once lab results identify the specific bacteria. Research on patients with common bloodstream infections found that those whose antibiotics were de-escalated had significantly fewer complications from resistant organisms (0% versus 5.1%) with no meaningful difference in hospital stay length.
Who Runs the Program
A stewardship team is multidisciplinary by design. At its core, you’ll find an infectious disease physician and a clinical pharmacist who co-lead the effort. The physician provides clinical authority, making judgment calls on complex cases. The pharmacist reviews orders in real time, flags interactions, and often does the day-to-day work of auditing prescriptions and recommending alternatives.
Beyond those two, infection preventionists track resistance data and healthcare-associated infections, while nurses play a practical role in flagging opportunities for intervention, like identifying patients who could switch from IV to oral antibiotics. Microbiology lab staff contribute by providing timely culture results that allow the team to narrow or stop therapy. The program functions best when these roles are formalized with dedicated time rather than added onto existing workloads.
Regulatory Requirements
Antibiotic stewardship is no longer voluntary for accredited facilities. The Joint Commission requires hospitals, critical access hospitals, and nursing care centers to have a functioning stewardship program. Their standards mandate a multidisciplinary team that includes an infectious disease physician, an infection preventionist, a pharmacist, and a practitioner. Facilities must use organization-approved protocols for things like formulary restrictions, prescribing guidelines, and switching patients from IV to oral antibiotics. They must also collect and analyze data on program performance and act on what they find.
On the federal side, the Centers for Medicare and Medicaid Services ties stewardship to its Promoting Interoperability Program. Eligible hospitals and critical access hospitals must actively report antimicrobial use and resistance data to the CDC’s National Healthcare Safety Network. Failing to report results in a score of zero for that portion of the program, which can affect reimbursement.
Stewardship in Nursing Homes
Long-term care facilities face unique challenges. They typically have fewer on-site physicians, limited pharmacy resources, and a resident population that is especially vulnerable to both infections and antibiotic side effects. The CDC adapted its hospital core elements for nursing homes, keeping the same seven categories but scaling expectations to match smaller staffing models.
In a nursing home, stewardship might mean establishing access to a consultant pharmacist with antibiotic expertise rather than hiring one full-time. The “action” element requires implementing at least one policy to improve use, which could be as focused as creating a protocol for when to send a urine culture versus treating based on symptoms alone (a major source of unnecessary antibiotic prescriptions in older adults). Tracking requires monitoring at least one process measure, like how often antibiotics are prescribed for urinary symptoms, and at least one outcome measure. Education extends to residents and their families, who often expect antibiotics for conditions that don’t require them.
Stewardship in Outpatient Settings
Most antibiotic prescriptions are written outside hospitals, in primary care offices, urgent care clinics, and emergency departments. The CDC’s outpatient core elements are streamlined into four categories: leadership commitment, action, tracking and reporting, and education and expertise.
The strategies here look different from hospital-based programs. Watchful waiting, for example, applies to conditions like mild ear infections in children, where a clinician holds off on prescribing and monitors for a day or two to see if the infection resolves on its own. Delayed prescribing gives the patient a prescription but asks them to wait 48 to 72 hours before filling it, using it only if symptoms worsen. Some clinics use “symptom relief prescription pads” that recommend over-the-counter remedies for viral illnesses, giving patients something concrete to walk away with instead of an antibiotic that won’t help.
Tracking in outpatient settings often means clinicians reviewing their own prescribing data. Seeing that you prescribe antibiotics for bronchitis at twice the rate of your peers is a powerful motivator to change behavior. Peer comparison reports have been one of the most effective tools for reducing unnecessary outpatient prescribing.